Skip to main content
Premium Trial:

Request an Annual Quote

GE Healthcare, Merck Collaborating on Lung Imaging Tech Trial

NEW YORK (GenomeWeb News) – GE Healthcare said today it has signed an agreement giving the drugmaker Merck access to a molecular imaging agent GE is developing for high-speed, quantitative lung imaging.
The company said the collaborators will evaluate GE Healthcare’s Spin Signal Technology to determine if it can help researchers study the functioning of diseased lungs using modified xenon gas in conjunction with magnetic resonance imaging scans.
The companies will be able to assess the effects of potential therapeutics in real-time in animal models, GE said.
Kim Gallagher, who is head of external scientific affairs in the medical diagnostics division of GE Healthcare, said that the agreement gives Merck access to the SST and to the modified xenon trial data and will “monitor its potential and plan for its possible incorporation in therapy trials.”

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.